Virginia Ransom
Adult Health · Plano, TXNPI 1386077246
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 421 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 54 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 421 payments — averaging $16.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$903
- AbbVie$872
- AstraZeneca$715
- Lilly USA, LLC$627
- Johnson & Johnson$365
- GSK$334
- plus $3K from 48 others
What the payments were for
- Food & beverage$7,049100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,049 in reported general payments places this provider in the 90th percentile of 933 adult health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 25 | $37,371 |
| EliquisApixaban | 37 | $35,831 |
| JardianceEmpagliflozin | 29 | $32,499 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $14,385 |
| PaxlovidNirmatrelvir/Ritonavir | 11 | $1,429 |
| Memantine Hcl ErMemantine Hcl | 17 | $1,252 |
| Levothyroxine Sodium | 102 | $920 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 41 | $882 |
| SynthroidLevothyroxine Sodium | 22 | $841 |
| Bupropion XlBupropion Hcl | 29 | $812 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 39 | $736 |
| Esomeprazole Magnesium | 14 | $649 |
| Atorvastatin Calcium | 95 | $619 |
| Potassium Chloride | 21 | $592 |
| Rosuvastatin Calcium | 91 | $573 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $903 | $37,37125 claims |
| PfizerEliquis, Paxlovid | $192 | $37,26048 claims |
| Boehringer IngelheimJardiance | $298 | $32,49929 claims |
| AstraZenecaBreztri Aerosphere | $715 | $14,38513 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $107 | $920102 claims |
| AbbVieSynthroid | $872 | $84122 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 933 adult health providers in Texas.
Other adult health in Plano
- Cynthia BedellPlano$168K
- Catherine KamauPlano$13K
- Stephani ElliottPlano$9K
- Misty SheddAllen$863K
- Melodie YoungDallas$700K
- Elizabeth Wedberg SivamAustin$71K
- Mary SalazarSan Antonio$68K
- Eric KlappholzDallas$44K
- Christin TouchetKingwood$43K
- Yulia LyuboslavskyAustin$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.